Lauren B. Gerson MD, MSc

Publications

• A multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscope. Choi EH, Mergener K, Semrad C, Fisher L, Cave DR, Dodig M, Burke C, Leighton JA, Kastenberg D, Simpson P, Sul J, Bhattacharya K, Charles R, Gerson L, Weber L, Eisen G, Reidel W, Vargo JJ, Wakim-Fleming J, Lo SK. Gastrointest Endosc. 2013
• Clinical guideline: management of gastroparesis. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Am J Gastroenterol. 2013; 108 (1): 18-37; quiz 38
• Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy. Mody R, Eisenberg D, Hou L, Kamat S, Singer J, Gerson LB. Clinicoecon Outcomes Res. 2013: 5 161-9
• Guidelines for the diagnosis and management of gastroesophageal reflux disease. Katz PO, Gerson LB, Vela MF. Am J Gastroenterol. 2013; 108 (3): 308-28; quiz 329
• Small-bowel enteroscopy. Gerson LB, Endoscopy. 2013; 45 (4): 292-5
• The final word on proton pump inhibitors and osteoporosis? Gerson LB, Gastroenterology. 2013; 144 (3): 650-2
• Use and Misuse of Small Bowel Video Capsule Endoscopy in Clinical Practice. Gerson LB, Clin Gastroenterol Hepatol. 2013
• Variation of health-care resource utilization according to GERD-associated complications. Gerson LB, McLaughlin T, Balu S, Jackson J, Lunacsek O. Dis Esophagus. 2012 Nov-Dec; 25 (8): 694-701
• Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy. Gerson LB, Mitra S, Bleker WF, Yeung P. Aliment Pharmacol Ther. 2012; 35 (7): 803-9
• Gastroenterologists and the US opioid epidemic. Gerson LB, Gastroenterology. 2012; 142 (5): 1250-3
• Is there a consensus about eosinophilic esophagitis? Gerson LB, Gastroenterology. 2012; 143 (1): 260-2; discussion 262
• Is there a role for angiography in patients with obscure overt bleeding? Gerson LB, Am J Gastroenterol. 2012; 107 (9): 1377-9
• Lack of significant interactions between clopidogrel and proton pump inhibitor therapy: meta-analysis of existing literature. Gerson LB, McMahon D, Olkin I, Stave C, Rockson SG. Dig Dis Sci. 2012; 57 (5): 1304-13
• Small bowel endoscopy: cost-effectiveness of the different approaches. Gerson LB, Best Pract Res Clin Gastroenterol. 2012; 26 (3): 325-35
• The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. Hershcovici T, Jha LK, Gadam R, Cui H, Gerson L, Thomson S, Fass R. J Clin Gastroenterol. 2012; 46 (8): 662-8
• Time to consider medical therapy for small-bowel angioectasias. Gerson LB, Jackson C. Am J Gastroenterol. 2012; 107 (9): 1442-3
• Are we ready for gender-based guidelines for Barrett's esophagus screening? Gerson LB, Gastroenterology. 2011; 141 (6): 2271-3
• Barrett's esophagus: endoscopic diagnosis. Ishimura N, Amano Y, Appelman HD, Penagini R, Tenca A, Falk GW, Wong RK, Gerson LB, Ramirez FC, Horwhat JD, Lightdale CJ, DeVault KR, Freschi G, Taddei A, Bechi P, Ringressi MN, Castiglione F, Rossi Degl'Innocenti D, Wang HH, Huang Q, Bellizzi AM, Lisovsky M, Srivastava A, Riddell RH, Johnson LF, Saunders MD, Chuttani R. Ann N Y Acad Sci. 2011: 1232 53-75
• Barrett's esophagus: surveillance and reversal. Caygill CP, Dvorak K, Triadafilopoulos G, Felix VN, Horwhat JD, Hwang JH, Upton MP, Li X, Nandurkar S, Gerson LB, Falk GW. Ann N Y Acad Sci. 2011: 1232 196-209
• Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. Miller SM, Goldstein JL, Gerson LB. Am J Gastroenterol. 2011; 106 (8): 1439-45
• Development of a refractory gastro-oesophageal reflux score using an administrative claims database. Gerson LB, Bonafede M, Princic N, Gregory C, Farr A, Balu S. Aliment Pharmacol Ther. 2011; 34 (5): 555-67
• Impact of inpatient status and gender on small-bowel capsule endoscopy findings. Robinson CA, Jackson C, Condon D, Gerson LB. Gastrointest Endosc. 2011; 74 (5): 1061-6
• Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Gerson LB, Kahrilas PJ, Fass R. Clin Gastroenterol Hepatol. 2011; 9 (10): 824-33
• Proton pump inhibitors and safety during pregnancy. Gerson LB, Gastroenterology. 2011; 141 (1): 389-91
• Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Hershcovici T, Jha LK, Johnson T, Gerson L, Stave C, Malo J, Knox KS, Quan S, Fass R. Aliment Pharmacol Ther. 2011; 34 (11-12): 1295-305
• The tincture of time and irritable bowel syndrome symptoms. Gerson LB, Gastroenterology. 2011; 140 (5): 1680-2
• Adverse events associated with anticoagulation therapy in the periendoscopic period. Gerson LB, Michaels L, Ullah N, Gage B, Williams L. Gastrointest Endosc. 2010; 71 (7): 1211-1217.e2
• Antidepressants for irritable bowel syndrome: reappraisal for the nondepressed. Gerson LB, Gastroenterology. 2010; 138 (2): 775-7
• Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Gerson LB, Huff FJ, Hila A, Hirota WK, Reilley S, Agrawal A, Lal R, Luo W, Castell D. Am J Gastroenterol. 2010; 105 (6): 1266-75
• Diagnostic yield of upper endoscopy in treated GERD patients. Gerson LB, Gastroenterology. 2010; 139 (4): 1408-9
• Good night, sleep tight ... and don't let the acid bite! Gerson LB, Gastroenterology. 2010; 138 (7): 2551-3
• Long-term impact of capsule endoscopy in patients referred for iron-deficiency anemia. Sheibani S, Levesque BG, Friedland S, Roost J, Gerson LB. Dig Dis Sci. 2010; 55 (3): 703-8
• Systematic review: the effects of carbonated beverages on gastro-oesophageal reflux disease. Johnson T, Gerson L, Hershcovici T, Stave C, Fass R. Aliment Pharmacol Ther. 2010; 31 (6): 607-14
• Timing, timing, timing of deep enteroscopy! A key factor for diagnosis of small intestinal hemorrhage, but does it impact patient outcomes? Gerson LB, Gastroenterology. 2010; 139 (6): 2215-7; discussion 2217
• Screening for esophageal varices: is esophageal capsule endoscopy ready for prime time? Gerson LB, J Clin Gastroenterol. 2009 Nov-Dec; 43 (10): 899-901
• A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Gerson LB, Fass R. Clin Gastroenterol Hepatol. 2009; 7 (4): 372-8; quiz 367
• Capsule endoscopy and deep enteroscopy: indications for the practicing clinician. Gerson LB, Gastroenterology. 2009; 137 (4): 1197-201
• Complications associated with double balloon enteroscopy at nine US centers. Gerson LB, Tokar J, Chiorean M, Lo S, Decker GA, Cave D, Bouhaidar D, Mishkin D, Dye C, Haluszka O, Leighton JA, Zfass A, Semrad C. Clin Gastroenterol Hepatol. 2009; 7 (11): 1177-82, 1182.e1-3
• Endoscopic mucosal resection for early esophageal cancer--replacement for esophagectomy? Gerson LB, Gastroenterology. 2009; 136 (1): 359-60
• Impact of obesity on endoscopy. Gerson LB, Gastrointest Endosc. 2009; 70 (4): 758-62
• Long-Term Outcomes after Double Balloon Enteroscopy for Obscure Gastrointestinal Bleeding. Gerson LB, Batenic MA, Ross A, Semrad C. Clin Gastroenterol Hepatol. 2009
• Long-term outcomes after double-balloon enteroscopy for obscure gastrointestinal bleeding. Gerson LB, Batenic MA, Newsom SL, Ross A, Semrad CE. Clin Gastroenterol Hepatol. 2009; 7 (6): 664-9
• Outcomes associated with deep enteroscopy. Gerson LB, Gastrointest Endosc Clin N Am. 2009; 19 (3): 481-96
• Preparation before capsule endoscopy: the value of the purge. Gerson LB, Gastroenterology. 2009; 137 (3): 1166-8; discussion 1168
• Recurrent gastrointestinal bleeding after negative upper endoscopy and colonoscopy. Gerson LB, Clin Gastroenterol Hepatol. 2009; 7 (8): 828-33
• Risk factors for the detection of Barrett's esophagus in patients with erosive esophagitis. Modiano N, Gerson LB. Gastrointest Endosc. 2009; 69 (6): 1014-20
• Risk of perforation from a colonoscopy in adults: a large population-based study. Arora G, Mannalithara A, Singh G, Gerson LB, Triadafilopoulos G. Gastrointest Endosc. 2009; 69 (3 Pt 2): 654-64
• Screening for Barrett's esophagus in asymptomatic women. Gerson LB, Banerjee S. Gastrointest Endosc. 2009; 70 (5): 867-73
• Small bowel imaging for Crohn's disease: camera, contrast, or scope? Sharaf R, Gerson LB. Gastroenterology. 2009; 136 (5): 1828-30
• Balloon-assisted enteroscopy: technology and troubleshooting. Gerson LB, Flodin JT, Miyabayashi K. Gastrointest Endosc. 2008; 68 (6): 1158-67
• Bariatric surgery and life expectancy. Gerson LB, Gastroenterology. 2008; 134 (1): 358-9
• Chemical colitis. Sheibani S, Gerson LB. J Clin Gastroenterol. 2008; 42 (2): 115-21
• Cost-effectiveness analysis of management strategies for obscure GI bleeding. Gerson L, Kamal A. Gastrointest Endosc. 2008; 68 (5): 920-36
• Do pregnant women with heartburn become adults with GERD? Gerson LB, Gastroenterology. 2008; 135 (3): 1003-5
• Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Ross A, Mehdizadeh S, Tokar J, Leighton JA, Kamal A, Chen A, Schembre D, Chen G, Binmoeller K, Kozarek R, Waxman I, Dye C, Gerson L, Harrison ME, Haluszka O, Lo S, Semrad C. Dig Dis Sci. 2008; 53 (8): 2140-3
• Preoperative endoscopic screening for laparoscopic Roux-en-Y gastric bypass has a low yield for anatomic findings. Mong C, Van Dam J, Morton J, Gerson L, Curet M, Banerjee S. Obes Surg. 2008; 18 (9): 1067-73
• Should all patients with acute gastrointestinal hemorrhage receive intravenous proton pump inhibitor therapy before endoscopy? Gerson LB, Gastroenterology. 2008; 135 (5): 1790-2; discussion 1792
• The inaccuracy of ICD-9-CM Code 530.2 for identifying patients with Barrett's esophagus. Jacobson BC, Gerson LB. Dis Esophagus. 2008; 21 (5): 452-6
• Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors. Gerson LB, Triadafilopoulos G, Sahbaie P, Young W, Sloan S, Robinson M, Miner PB, Gardner JD. BMC Gastroenterol. 2008: 8 15
• American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Raju GS, Gerson L, Das A, Lewis B. Gastroenterology. 2007; 133 (5): 1694-6
• American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Raju GS, Gerson L, Das A, Lewis B. Gastroenterology. 2007; 133 (5): 1697-717
• Are all proton pump inhibitors created equal? Gerson LB, Gastroenterology. 2007; 132 (4): 1622-4
• Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Modiano N, Gerson LB. Ther Clin Risk Manag. 2007; 3 (6): 1035-145
• Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus. Gerson L, Lin OS. Clin Gastroenterol Hepatol. 2007; 5 (3): 319-25
• Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease? Stoltey J, Reeba H, Ullah N, Sabhaie P, Gerson L. Aliment Pharmacol Ther. 2007; 25 (1): 83-91
• Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease? Gerson LB, Ullah N, Fass R, Green C, Shetler K, Singh G. Aliment Pharmacol Ther. 2007; 25 (9): 1079-86
• Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? Gerson LB, Ullah N, Hastie T, Goldstein MK. Gastrointest Endosc. 2007; 65 (1): 16-25
• Does gender affect career satisfaction and advancement in gastroenterology? Results of an AGA institute-sponsored survey. Gerson LB, Twomey K, Hecht G, Lee L, McQuaid K, Pizarro TT, Street S, Yoshida C, Early D. Gastroenterology. 2007; 132 (4): 1598-606
• Initial capsule endoscopy or angiography in patients with obscure gastrointestinal bleeding? Gerson LB, Gastroenterology. 2007; 133 (4): 1382-3
• Pneumatic dilation or myotomy for achalasia? Gerson LB, Gastroenterology. 2007; 132 (2): 811-3
• Risk factors for small bowel bacterial overgrowth in cystic fibrosis. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. J Pediatr Gastroenterol Nutr. 2007; 44 (2): 212-8
• Too late for tegaserod? Efficacy for treatment of constipation in men. Gerson LB, Gastroenterology. 2007; 133 (2): 720-2
• A case of iron-deficiency anemia. Kamal A, Gerson LB. Clin Gastroenterol Hepatol. 2006; 4 (5): xxviii
• A little weight gain, how much gastroesophageal reflux disease? Gerson LB, Gastroenterology. 2006; 131 (5): 1644-6; discussion 1646
• Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Kaltenbach T, Crockett S, Gerson LB. Arch Intern Med. 2006; 166 (9): 965-71
• Can colonoscopy simulators enhance the learning curve for trainees? Gerson LB, Gastrointest Endosc. 2006; 64 (3): 369-74
• Clinical, radiologic, and manometric characteristics of chronic intestinal dysmotility: the Stanford experience. Rosa-E-Silva L, Gerson L, Davila M, Triadafilopoulos G. Clin Gastroenterol Hepatol. 2006; 4 (7): 866-73
• Evidence-based assessment of endoscopic simulators for training. Gerson LB, Gastrointest Endosc Clin N Am. 2006; 16 (3): 489-509, vii-viii
• Jejunal diverticulosis diagnosed by double-balloon enteroscopy. Kamal A, Gerson LB. Gastrointest Endosc. 2006; 63 (6): 864
• Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. Gerson LB, Gerson L, Friday K, Triadafilopoulos G. J Clin Gastroenterol. 2006; 40 (9): 828-32
• What is the learning curve associated with double-balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care centers. Mehdizadeh S, Ross A, Gerson L, Leighton J, Chen A, Schembre D, Chen G, Semrad C, Kamal A, Harrison EM, Binmoeller K, Waxman I, Kozarek R, Lo SK. Gastrointest Endosc. 2006; 64 (5): 740-50
• A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia. Gerson LB, Triadafilopoulos G. Dig Liver Dis. 2005; 37 (2): 87-91
• Acute colitis secondary to self-administered alcohol enemas: a mimic of ischemic colitis. Randolph M, Longacre TA, Gerson LB. J Clin Gastroenterol. 2005; 39 (1): 78-9
• Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus. Gerson LB, Shetler K, Triadafilopoulos G. Dig Liver Dis. 2005; 37 (9): 651-8
• Double-balloon enteroscopy: the new gold standard for small-bowel imaging? Gerson LB, Gastrointest Endosc. 2005; 62 (1): 71-5
• Patient-derived health state utilities for gastroesophageal reflux disease. Gerson LB, Ullah N, Hastie T, Triadafilopoulos G, Goldstein M. Am J Gastroenterol. 2005; 100 (3): 524-33
• Risk of proximal colon neoplasia with distal hyperplastic polyps: a meta-analysis. Lin OS, Gerson LB, Soon MS, Schembre DB, Kozarek RA. Arch Intern Med. 2005; 165 (4): 382-90
• Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Milkes D, Gerson LB, Triadafilopoulos G. Am J Gastroenterol. 2004; 99 (6): 991-6
• Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Gerson LB, Groeneveld PW, Triadafilopoulos G. Clin Gastroenterol Hepatol. 2004; 2 (10): 868-79
• Features of gastroesophageal reflux disease in women. Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G. Am J Gastroenterol. 2004; 99 (8): 1442-7
• Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors. Gerson LB, Boparai V, Ullah N, Triadafilopoulos G. Aliment Pharmacol Ther. 2004; 20 (6): 637-43
• Technology review: the use of simulators for training in GI endoscopy. Gerson LB, Van Dam J. Gastrointest Endosc. 2004; 60 (6): 992-1001
• The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis. Gerson LB, Triadafilopoulos G, Gage BF. Am J Med. 2004; 116 (7): 451-9
• Wireless capsule endoscopy and double-balloon enteroscopy for the diagnosis of obscure gastrointestinal bleeding. Gerson LB, Van Dam J. Tech Vasc Interv Radiol. 2004; 7 (3): 130-5
• A prospective randomized trial comparing a virtual reality simulator to bedside teaching for training in sigmoidoscopy. Gerson LB, Van Dam J. Endoscopy. 2003; 35 (7): 569-75
• Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus. Yeh RW, Gerson LB, Triadafilopoulos G. Dis Esophagus. 2003; 16 (3): 193-8
• Prevalence of Barrett's esophagus in asymptomatic individuals. Gerson LB, Shetler K, Triadafilopoulos G. Gastroenterology. 2002; 123 (2): 461-7
• Screening for esophageal adenocarcinoma: an evidence-based approach. Gerson LB, Triadafilopoulos G. Am J Med. 2002; 113 (6): 499-505
• The future of simulators in GI endoscopy: an unlikely possibility or a virtual reality? Gerson LB, Van Dam J. Gastrointest Endosc. 2002; 55 (4): 608-11
• Is colorectal cancer screening necessary in the preoperative assessment of inguinal herniorrhaphy? A case-control study. Gerson LB, Triadafilopoulos G. Am J Gastroenterol. 2001; 96 (6): 1914-7
• Proton pump inhibitors and their drug interactions: an evidence-based approach. Gerson LB, Triadafilopoulos G. Eur J Gastroenterol Hepatol. 2001; 13 (5): 611-6
• Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Gerson LB, Edson R, Lavori PW, Triadafilopoulos G. Am J Gastroenterol. 2001; 96 (7): 2005-12
• A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. Gerson LB, Robbins AS, Garber A, Hornberger J, Triadafilopoulos G. Am J Gastroenterol. 2000; 95 (2): 395-407
• Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease. Gerson LB, Hatton BN, Ryono R, Jones W, Pulliam G, Sampliner RE, Triadafilopoulos G, Fass R. Aliment Pharmacol Ther. 2000; 14 (4): 397-406
• Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. Gerson LB, Gage BF, Owens DK, Triadafilopoulos G. Am J Gastroenterol. 2000; 95 (7): 1717-24
• Palliative care in inflammatory bowel disease: an evidence-based approach. Gerson LB, Triadafilopoulos G. Inflamm Bowel Dis. 2000; 6 (3): 228-43
• Endoscopic band ligation for actively bleeding Dieulafoy's lesions. Gerson LB, Yap E, Slosberg E, Soetikno RM. Gastrointest Endosc. 1999; 50 (3): 454-5
• Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, Wiesner RH, Gershwin ME. Hepatology. 1996; 24 (5): 1079-84